The Traderszone Network

Emergent BioSolutions (NYSE: EBS) released solid first-quarter results last week. The next few quarters are up in the air due to the transition of the company’s biodefense contract with the government, but management seems unfazed about Emergent’s long-term prospects.

Metric

Q1 2016 Actuals

Continue reading

PBOC injects 30bn yuan via 7-day reverse repos
  CNY to weakest since March 4          
PBOC has drained a net 110bn yuan this week

Stocks wiggled in and out of positive territory on Thursday before ending the trading session nearly unchanged. By the closing bell, the Dow Jones Industrial Average (DJINDICES: ^DJI) had gained just 10 points, or less than 0.1%, and the S&P 500 (SNPINDEX: ^GSPC) held steady at 2,064 points:

read more

A shockingly frank new book from an anonymous Democratic congressman turns yet another set of conspiracy theories into consirpacy facts as he spills the beans on the ugly reality behind the scenes in Washington.

read more

Dividend aristocrats are companies in the S&P 500 that have raised their dividends annually for at least 25 years. Just over 50 stocks meet those conditions, and many of them have rallied over the past few years thanks to low interest rates and a flight to “safer” stocks.

Today, however, we’ll discuss two unloved dividend aristocrats which didn’t rally over the past year, and see if either one has become a bargain for income investors.

read more

An Israel-based supplier of autopilot components, Mobileye NV, has secured agreements with two auto makers to provide systems for fully autonomous cars in 2019, deals that give a clearer timetable for when auto makers believe they can start producing vehicles entirely capable of driving themselves.
read more

Japan finance minister Aso announces the Cabinet has approved an extra budget for the Kumamoto quake
– To remove rubble, fix infrastructure
Japan economy minister Ishihara is taking up the cudgels: